Individualization of Therapy for Hypertension in the 1990′S: The Role of Calcium Antagonists

References

• The Fifth Report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure. Arch Int Med 1993; 153(2)154–183
   PubMed Web of Science ®Google Scholar
• The 1988 Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988; 148: 1023–1038
   PubMed Web of Science ®Google Scholar
• Prisant L M, Carr A. Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and mass. Am J Hypertens 1990; 3: 81–89
   PubMed Web of Science ®Google Scholar
• Koren M J, Devereux R B, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Int Med 1991; 114(5)345–52
   PubMed Web of Science ®Google Scholar
• ter Keurs H EDJ, Savage D D, Lester W M, et al. New perspectives on left ventricular hypertrophy: anatomy, physiology, and significance. Clin Cardiol 1989; 12: IV-36–49
   Google Scholar
• Dahlof J, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95–110
   PubMed Web of Science ®Google Scholar
• Messerli F H, Nunez B D, Nunez M M, et al. Hypertension and sudden death: disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias. Arch Intern Med 1989; 149: 1263–1267
   PubMed Web of Science ®Google Scholar
• Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II - DAVIT II). Am J Cardiol 1990; 66: 779–785
   PubMed Web of Science ®Google Scholar
• Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. NEJM 1988; 319: 385–92
   PubMed Web of Science ®Google Scholar
• Hof R P. Comparison of cardiodepressant and vasodilator effects of PN 200–110 (isradipine), nifedipine and diltiazem in anesthetized rabbits. Am J Cardiol 1987; 59: 37B–42B
   PubMed Web of Science ®Google Scholar
• Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827–838
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255–3264
   PubMed Web of Science ®Google Scholar
• MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405–412
   PubMed Web of Science ®Google Scholar
• Lee D P, Rigonan K, DeQuattro V. Increased blood pressure and neural tone in the silent ischemia of hypertension: disparate effects of immediate release nifedipine. JACC 1993; 22(5)1438–45
   Google Scholar
• Lee D P, De Kimura S., Quattro V. Noradrenergic activity and silent ischaemia in hypertensives with stable angina: effect of metoprolol. Lancet 1989; 1(8635)403–406
   PubMedGoogle Scholar
• Gottlieb S O, Weisfeldt M L, Ouyang P, et al. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial. Circulation 1986; 73: 331–7
   PubMed Web of Science ®Google Scholar
• Parmley W W, Nesto R W, Singh B M, et al. Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. J Am Coll Cardiol 1992; 19: 1380–9
   PubMed Web of Science ®Google Scholar
• Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429–135
   PubMed Web of Science ®Google Scholar
• Yusuf S, Pepine C, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992; 340: 1173–78
   PubMed Web of Science ®Google Scholar
• Jackson R, Barham P, Maling T, et al. The management of raised blood pressure in New Zealand. BMJ 1993; 307: 107–10
   PubMed Web of Science ®Google Scholar
• Bakris G, Barnhill B, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 1992; 41: 912–919
   PubMed Web of Science ®Google Scholar
• Warram J, Laffel L M, Valsania P, et al. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Int Med 1992; 151: 1350–1356
   Web of Science ®Google Scholar
• Lewis E J, Hunsicker L G, Bain R P, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. NEJM 1993; 329: 1456
   PubMed Web of Science ®Google Scholar
• Neaton J D, Grimm R H, Prineas R J, et al. Treatment of mild hypertension study. JAMA 1993; 270: 713–724
   PubMed Web of Science ®Google Scholar
• Saunders E, Weir M R, Kong W, et al. A comparison of the efficacy and safety of a bT-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Int Med 1990; 150: 1707–1713
   PubMed Web of Science ®Google Scholar
• Julius S, Jamerson K, Mejia A, et al. The association of borderline hypertension with target organ changes and higher coronary risk. JAMA 1990; 264: 354–358
   PubMed Web of Science ®Google Scholar
• Mason R P, Campbell S F, Wang S, et al. Comparison of location and binding for the positively charged 1,4–dihydropyridine calcium channel antagonist amlodipine with uncharged drogs of this class in cardiac membranes. Mol Pharmacol 1993; 36: 634–640
   Google Scholar
• Jain A K, McMahon F G. 24–Hour blood pressure response to two slow-release verapamil formulations in patients with mild to moderate hypertension. Cardiovasc Reviews & Reports 1993; 14(4)45–51
   Google Scholar
• Carr A A, Bottini P B, Prisant L M, et al. Once-daily verapamil in the treatment of mild-to-moderate hypertension: a double-blind placebo-controlled dose-ranging study. J Clin Pharmacol 1991; 31: 144–150
   PubMed Web of Science ®Google Scholar
• Egashira K, Pipers F S, Rush J, Morgan J P. Effects of calcium channel blockers on coronary vasoconstriction induced by endothelin-1 in closed chest pigs. JACC 1990; 16(5)1296–303
   Google Scholar
• DeQuattro V. “Benazepril compared with other antihypertensive agents, singly and in combination - a review,”. Benazepril: Profile of a New ACE Inhibitor, H. R. Brunner, A. Salvetti, P. S. Sever. Royal Society of Medicine Services Ltd. 1990; 91–98
   Google Scholar